Dolores Cahill - Why People Will Begin Dying a Few Months After Receiving the Vaccine

Dolores Cahill: Why People Will Begin Dying a Few Months After Receiving the Vaccine

January 19, 2021 6:54 PM By Expat Gal 18 Comments

Dolores Cahill, Molecular Biologist & Immunologist – Ireland

***By injecting messenger RNA if it has protein from the virus like the spike protein, this plus positive RNA can go into our cells. The spike protein from the virus is expressed in our cells and may be exposed to the immune system when those cells die and the body starts mounting an immune response including an antibody response.***

PROFESSOR DOLORES CAHILL:
WHY PEOPLE WILL START DYING A FEW MONTHS AFTER THE FIRST MRNA VACCINATION

12:36 Minute Video on Bitchute

If people were vaccinated in December, then in 2-3 weeks the process would start. If in February, March or April, another coronavirus is circulating naturally in 2021, that would be like a challenge to the immune system of a vaccinated person with the natural coronavirus (like SARS) or even the common cold.

What happened in the study, the animal models got very sick & some of them died. Last sentence of study – “However, challenge of mice given any of the vaccines led to occurrence of Th2-type immunopathology suggesting hypersensitivity to SARS-CoV components was induced. Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated.”

Watch & listen carefully from 4 Minutes on where she explains how a person’s body who has been vaccinated with mRNA genes reacts!

The name for this thing is antibody dependence response or cytokines storm or immunopriming or immuno superpriming. This is why there has been no vaccine licensed for decades for the coronavirus!

Could be one month to one to two years and then people get very sick and will die quickly. Many children given the SARS vaccine (Two children out of 35 children) died. What was concluded was that the disease was enhanced by the prior vaccines!

Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus (April 2012 Study)

Abstract

Background: Severe acute respiratory syndrome (SARS) emerged in China in 2002 and spread to other countries before brought under control. Because of a concern for reemergence or a deliberate release of the SARS coronavirus, vaccine development was initiated. Evaluations of an inactivated whole virus vaccine in ferrets and nonhuman primates and a virus-like-particle vaccine in mice induced protection against infection but challenged animals exhibited an immunopathologic-type lung disease.

Design: Four candidate vaccines for humans with or without alum adjuvant were evaluated in a mouse model of SARS, a VLP vaccine, the vaccine given to ferrets and NHP, another whole virus vaccine and an rDNA-produced S protein. Balb/c or C57BL/6 mice were vaccinated IM on day 0 and 28 and sacrificed for serum antibody measurements or challenged with live virus on day 56. On day 58, challenged mice were sacrificed and lungs obtained for virus and histopathology.

Results: All vaccines induced serum neutralizing antibody with increasing dosages and/or alum significantly increasing responses. Significant reductions of SARS-CoV two days after challenge was seen for all vaccines and prior live SARS-CoV. All mice exhibited histopathologic changes in lungs two days after challenge including all animals vaccinated (Balb/C and C57BL/6) or given live virus, influenza vaccine, or PBS suggesting infection occurred in all. Histopathology seen in animals given one of the SARS-CoV vaccines was uniformly a Th2-type immunopathology with prominent eosinophil infiltration, confirmed with special eosinophil stains. The pathologic changes seen in all control groups lacked the eosinophil prominence.

Conclusions: These SARS-CoV vaccines all induced antibody and protection against infection with SARS-CoV. However, challenge of mice given any of the vaccines led to occurrence of Th2-type immunopathology suggesting hypersensitivity to SARS-CoV components was induced. 

Caution in proceeding to application of a SARS-CoV vaccine in humans is indicated.”

https://z3news.com/w/dolores-cahill-people-dying-months-receiving-vaccine/

___